Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

PHASE2/PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2004

Study Completion Date

December 31, 2007

Conditions

Overactive Bladder

Interventions

DRUG

Tolterodine 4 mg

DRUG

arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks

Trial Locations (1)

Department of Gynecology and Obstetrics - Università dell'Insubria, Varese

All Listed Sponsors

lead

Università degli Studi dell'Insubria

OTHER

NCT00648310 - Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity | Biotech Hunter | Biotech Hunter